Trial
NCT04037462
Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
VA Office of Research and Development
Collaborators
Wayne State University; University of Michigan; Barbara Ann Karmanos Cancer Institute
Condition
Non-Small Cell Lung Cancer
Intervention
Dexamthasone
Why stopped
Low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-14